Haemopoietic cell transplantation in patients living with HIV
Haemopoietic cell transplantation is established as a standard treatment approach for people living with HIV who have haematological malignancies with poor prognosis. Studies with autologous and allogeneic haemopoietic cell transplantation suggest that HIV status does not adversely affect outcomes,...
Saved in:
Published in | The lancet HIV Vol. 7; no. 9; p. e652 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
01.09.2020
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Summary: | Haemopoietic cell transplantation is established as a standard treatment approach for people living with HIV who have haematological malignancies with poor prognosis. Studies with autologous and allogeneic haemopoietic cell transplantation suggest that HIV status does not adversely affect outcomes, provided that there is adequate infection prophylaxis. Attention to possible drug-drug interactions is important. Allogeneic haemopoietic cell transplantation substantially reduces the long-term HIV reservoir when complete donor chimerism is established. When transplants from CCR5Δ32 homozygous donors are used, HIV cure is possible. |
---|---|
ISSN: | 2352-3018 |
DOI: | 10.1016/S2352-3018(20)30117-X |